Evidence map›Paper›PMID 42124561›Full record

ArticlebioRxiv : the preprint server for biology2026

Regulatory T cells restrain IL-15-mediated cytotoxic and bystander T cell activity in mucosal tissue without compromising antigen-driven memory.

Irene Cruz Talavera, Jessica B Graham, Jessica L Swarts, Brianna R Traxinger, M Quinn Peters, Lakshmi Warrier, Amanda L Koehne, Tanvi Arkatkar, Keith R Jerome, Martin Prlic and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Irene Cruz TalaveraVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Jessica B GrahamVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Jessica L SwartsVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Brianna R TraxingerVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
M Quinn PetersVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Lakshmi WarrierVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Amanda L KoehneExperimental Histopathology, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Tanvi ArkatkarVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Keith R JeromeVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Martin PrlicVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-0685-9321
Jennifer M LundVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0003-3284-979X

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host ImmunityR01AI123323 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRLIC, MARTIN · 2017 to 2025
$5.0M
The regulatory role of natural progesterone in barrier immunityR01AI172111 · NIAID · UNIVERSITY OF WASHINGTON · PI Florian Hladik, Jennifer M Lund · 2022 to 2026
$4.3M
Tissue Regulatory T Cells in Mucosal InfectionR01AI141435 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LUND, JENNIFER M · 2019 to 2023
$3.2M
Viral Pathogenesis Training ProgramT32AI083203 · NIAID · UNIVERSITY OF WASHINGTON · PI BLOOM, JESSE D, LAGUNOFF, MICHAEL · 2009 to 2023
$2.7M
NCI NIH HHS P30 CA015704NIAID NIH HHS R01 AI123323NIAID NIH HHS R01 AI141435NIAID NIH HHS R01 AI172111NIAID NIH HHS T32 AI007140NIAID NIH HHS T32 AI083203
6 · The paper itself

Abstract

Many pathogenic human infections enter the host via a mucosal surface. These nonlymphoid tissues are abundantly populated by polyclonal memory CD8 T cells that persist following infections to protect the host in the event of repeat exposure. Memory T cells can be triggered via T cell receptor (TCR) interaction with their cognate antigen upon re-infection to exert effector functions, including cytotoxicity and cytokine production, and assist in pathogen elimination. Alternatively, some T cells are 'bystander activated' by cytokines without antigenic signal. This layered approach boosts efficient pathogen clearance but also poses a threat to host tissues if this response is not properly controlled. Here we investigate the regulatory mechanisms modulating the tissue memory CD8 T cell response upon recall, leveraging mouse models to distinguish antigen-driven versus cytokine-activated memory tissue CD8 T cell immunity. We find that regulatory T cells (Treg) play a role in restricting cytotoxic and bystander activity in mucosal T cells without compromising the antigen-driven protective memory CD8 T cell response. Critically, Treg provide extrinsic regulation of tissue CD8 T cell cytotoxicity through restriction of available IL-2 and IL-15 trans-presentation. Our findings help to define the extrinsic environmental and cellular cues in mucosal tissues that direct tissue memory CD8 T cell cytotoxicity.

Identifiers

PMID42124561
PMCPMC13159997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.